A Phase I Dose Escalation Trial of Clofarabine in Addition to Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients With Relapsed or Refractory Acute Leukemia.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 Jan 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Clofarabine (Primary) ; Dexamethasone; Dexamethasone; Filgrastim; Thiotepa; Topotecan; Vinorelbine
Indications Acute biphenotypic leukaemia; Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
Focus Adverse reactions; Therapeutic Use

04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
15 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com